3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
41
NIH
14
NETWORK
13
INDUSTRY
4
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
1
Interventions
Cisplatin
6
Radiotherapy
4
Hydralazine
3
Gemcitabine
3
Valproic Acid
2
Probiotics
2
Paclitaxel
2
Drug Therapy
2
Brachytherapy
2
spartalizumab
1
nimotuzumab
1
belotecan
1
apatinib
1
Therapeutics
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiotherapy, Intensity-Modulated
1
Radiation Dose Hypofractionation
1
Proto-Oncogene Proteins c-raf
1
Neoadjuvant Therapy
1
Nelfinavir
1
Mobile Health Units
1
Magnetic Resonance Spectroscopy
1
Magnesium
1
Injections
1
Immune Checkpoint Inhibitors
1
Hysteroscopy
1
Heart Rate
1
Fatty Acids, Omega-3
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Uterine Cervical Neoplasms
×
Brachytherapy
×
Clear all
NCT03256916
2026-02-24
NELCER
Tata Memorial Hospital
Phase 3
Completed
348 enrolled
NCT02957266
2016-11-15
CERVIPIB
The National Center of Oncology, Azerbaijan
Phase 3
Unknown
400 enrolled